Another systematic meta-analysis of randomized controlled and observational studies [139] demonstrated a significant decrease in hospitalizations for HF in patients treated with SGLT-2 inhibitors compared to placebo or other antidiabetes drugs for type II diabetes. The gene discussed is SLC5A2; the disease is hydrops fetalis.